Richard Aranda - Jun 22, 2023 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role
Chief Medical Officer
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
Stock symbol
GOSS
Transactions as of
Jun 22, 2023
Transactions value $
-$2,340
Form type
4
Date filed
6/26/2023, 04:01 PM
Previous filing
May 9, 2023
Next filing
Nov 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GOSS Common Stock Sale -$2.34K -1.81K -0.91% $1.29 198K Jun 22, 2023 Direct F1, F2
holding GOSS Common Stock 2.54K Jun 22, 2023 By family trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
F2 This transaction was executed in multiple trades at prices ranging from $1.285 to 1.29 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.